This section is not available in the published analysis.
Lomecel-B: Audience
Lomecel-B is a cellular therapy developed by Longeveron, aimed at repairing and regenerating tissue affected by aging-related and life-threatening conditions. It is currently being tested in clinical trials for conditions such as Alzheimer’s disease and Hypoplastic Left Heart Syndrome.